Article

Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge

2021-08-31

Abstract excerpt

Early events in the host response to SARS-CoV-2 are thought to play a major role in determining disease severity. During pulmonary infection, the virus encounters both myeloid and epithelioid lineage cells that can either support or restrict pathogen replication as well as respond with host protective versus detrimental mediators. In addition to providing partial protection against pediatric tuberculosis, vaccinat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 31fee1be-69f4-53ad-815b-49abf3b3ceb9
DOI: 10.1101/2021.08.30.458273

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challengeDOI 10.1101/2021.08.30.458273Read

Pre-existing interferon gamma conditions the lung to mediate early control of SARS-CoV-2Semantic proximity Read

Dynamic Single-Cell RNA Sequencing Reveals that Intravenous BCG Vaccination Curtails SARS-CoV-2 Induced Disease Severity and Lung InflammationSemantic proximity Read

Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammationSemantic proximity Read

Bacillus Calmette-Guérin–induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 miceSemantic proximity Read

The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replicationSemantic proximity Read

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilizing immunity against SARS-CoV-2 infection in miceSemantic proximity Read

Protective intravenous BCG vaccination induces enhanced immune signaling in the airwaysSemantic proximity Read

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 TrialSemantic proximity Read

Contained Mycobacterium tuberculosis infection induces concomitant and heterologous protectionSemantic proximity Read

Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory MiceSemantic proximity Read

Improved Immune Responses and Tuberculosis Protection by Aerosol Vaccination with recombinant BCG expressing ESX-1 from <i>Mycobacterium marinum</i>Semantic proximity Read

BCG Vaccines: Their mechanisms of attenuation and impact on safety and protective efficacySemantic proximity Read